TY - JOUR
T1 - Postural tachycardia syndrome
T2 - Clinical features and follow-up study
AU - Sandroni, Paola
AU - Opfer-Gehrking, Tonette L.
AU - McPhee, Benjamin R.
AU - Low, Phillip A.
N1 - Funding Information:
This study was supported in part by grant PO1 NS32352 from the National Institutes of Health and by Mayo Foundation .
PY - 1999
Y1 - 1999
N2 - Objective: To define the clinical features and outcome of postural tachycardia syndrome (POTS). Materials and Methods: In this cross-sectional study of the autonomic symptom profile, inclusion criteria were orthostatic heart rate increment of 30 beats/min or greater, orthostatic symptoms, completion of a standardized autonomic test battery, and follow-up of 18 months or longer. We used 2 instruments. The first part was a structured and validated autonomic symptom profile (108 patients). The second part was a structured questionnaire focused on autonomic status on prospective follow-up (40 patients) (mean ± SD follow-up, 67±52 months). Results: Most patients had frequent, persistent, and at least moderately severe symptoms for less than 5 years. The following orthostatic symptoms occurred in more than 75% of subjects: light-headedness or dizziness, lower extremity or diffuse weakness, disequilibrium, tachycardia, and shakiness. Nonorthostatic symptoms included dry eyes or mouth, gastrointestinal complaints of bloating, early satiety, nausea, pain, and alternating diarrhea and constipation. Half of the patients reported an antecedent illness presumed to be of viral origin. On follow-up, 80% of patients were improved, 60% were functionally normal, and 90% were able to return to work. Patients who had an antecedent event appeared to do better than those with spontaneous POTS. Salt supplementation and β-blockers were the most efficacious therapies. Conclusion: In the majority of patients, POTS is self-resolving, especially in those with a triggering event.
AB - Objective: To define the clinical features and outcome of postural tachycardia syndrome (POTS). Materials and Methods: In this cross-sectional study of the autonomic symptom profile, inclusion criteria were orthostatic heart rate increment of 30 beats/min or greater, orthostatic symptoms, completion of a standardized autonomic test battery, and follow-up of 18 months or longer. We used 2 instruments. The first part was a structured and validated autonomic symptom profile (108 patients). The second part was a structured questionnaire focused on autonomic status on prospective follow-up (40 patients) (mean ± SD follow-up, 67±52 months). Results: Most patients had frequent, persistent, and at least moderately severe symptoms for less than 5 years. The following orthostatic symptoms occurred in more than 75% of subjects: light-headedness or dizziness, lower extremity or diffuse weakness, disequilibrium, tachycardia, and shakiness. Nonorthostatic symptoms included dry eyes or mouth, gastrointestinal complaints of bloating, early satiety, nausea, pain, and alternating diarrhea and constipation. Half of the patients reported an antecedent illness presumed to be of viral origin. On follow-up, 80% of patients were improved, 60% were functionally normal, and 90% were able to return to work. Patients who had an antecedent event appeared to do better than those with spontaneous POTS. Salt supplementation and β-blockers were the most efficacious therapies. Conclusion: In the majority of patients, POTS is self-resolving, especially in those with a triggering event.
UR - http://www.scopus.com/inward/record.url?scp=0033501302&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033501302&partnerID=8YFLogxK
U2 - 10.4065/74.11.1106
DO - 10.4065/74.11.1106
M3 - Article
C2 - 10560597
AN - SCOPUS:0033501302
SN - 0025-6196
VL - 74
SP - 1106
EP - 1110
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 11
ER -